👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

GLOBAL MARKETS-Stocks mostly lower, dollar steady, on jobs report, lockdowns

Published 11/20/2020, 12:22 AM
Updated 11/20/2020, 12:30 AM
© Reuters.
EUR/USD
-
US500
-
DJI
-
JP225
-
DX
-
IXIC
-
US10YT=X
-
FTEU3
-
MIAPJ0000PUS
-
MIWD00000PUS
-
MRNA
-

* World stocks down for third straight day
* Oil, bonds ease, dollar steadies after U.S. jobless claims
* COVID-19 infection rates surge in United States, Japan

By Alwyn Scott
NEW YORK, Nov 19 (Reuters) - Stocks were broadly lower on
Thursday, and oil prices slipped, as a weak reading on U.S.
employment and new COVID-19 restrictions offset recent optimism
about reported progress on coronavirus vaccines.
The dollar steadied and U.S. 10-year Treasury yields fell
after the U.S. reported an unexpectedly large rise in jobless
claims in the week ended Nov. 14.
The latest U.S. tally of new claims for unemployment
insurance showed 742,000 compared with 711,000 the prior week
and forecasts of 707,000 among economists polled by Reuters.

The dollar had been trending higher earlier in the day,
though its gains were tempered by renewed concern about further
monetary easing to shore up the economy.
The Dow Jones Industrial Average .DJI was down 0.16% and
the S&P 500 .SPX was off 0.33%, while the tech-heavy Nasdaq
Composite .IXIC had added 0.28%.
Positive news about possible vaccines had helped push the
MSCI World Index to a record high earlier in the week, but
investors pulled back as a host of countries announced record
infection rates and tougher lockdowns to curb the virus' spread.
The MSCI benchmark for global equity markets .MIWD00000PUS
fell 0.45% to 610.11. Europe's broad FTSEurofirst 300 index
.FTEU3 dropped 0.75% to 1,496.62.
The dollar index =USD rose 0.017%, with the euro EUR=
down 0.08% to $1.1843.
Treasuries Benchmark 10-year notes US10YT=RR rose 8/32 in
price to yield 0.857%, compared with 0.882% late on Wednesday.
The weaker sentiment was partly triggered by a late sell-off
in the U.S. on Wednesday. The S&P 500 .SPX closed down 1.1%,
following news that the country's COVID-19 deaths had passed
250,000, setting off a host of lockdowns. New York City's public
school system, the country's largest, halted in-classroom
instruction in response to rising infections rates. Similarly sombre news in Japan, which saw a record number of
cases and a rise in Tokyo's pandemic alert level, sent the
Nikkei .N225 down 0.4%. MSCI's broadest index of Asia-Pacific
shares outside Japan .MIAPJ0000PUS fell 0.8%. "The markets probably overshot the vaccine news and are
probably just retreating slightly now because case numbers are
going up," said Gavin Rochussen, chief executive of UK-based
asset manager Polar Capital.
The positive vaccine news had continued Wednesday after
Pfizer PFE.N said its COVID-19 vaccine was 95% effective and
it would apply for emergency U.S. authorization within days,
following a similar recent report from Moderna MRNA.O .
"The vaccines news are a positive medium-term impulse for
the global economic outlook and investors are trying to weigh
that against the prospect of an imminent stalling of the
European and U.S. recovery amid the prospect of extensions of
current lockdown measures," said Rodrigo Catril, a senior FX
strategist at NAB.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Asia stock markets https://tmsnrt.rs/2zpUAr4
Asia-Pacific valuations https://tmsnrt.rs/2Dr2BQA
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.